| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.085 | 0.03 |